Keyword: Johnson & Johnson
News
31.01.2013
- EU antitrust regulators stepped up their fight against companies blocking the market entry of cheaper generic medicines, with charges against Johnson & Johnson and Novartis over a...
News
22.01.2013
- Johnson & Johnson reported better-than-expected fourth-quarter earnings on Tuesday, due in part to a favorable tax rate, and said it is considering selling a $2 billion-a-year...
News
16.01.2013
- Drugmakers are betting that a new wave of medicines for cancer, diabetes, heart disease, multiple sclerosis and hepatitis will shape up as tomorrow's blockbusters in the coming 12...
News
02.01.2013
- U.S. regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after losing billions of dollars in recent years to...
News
21.12.2012
- U.S. drugmaker Eli Lilly agreed on Thursday to pay $29 million to settle civil charges that its subsidiaries made improper payments to foreign government officials to win business...
News
04.12.2012
- Drug companies are becoming more efficient in hunting for new treatments, though this has yet to be reflected in improved investment returns, according to a report on Tuesday. Low...
News
28.11.2012
- Drugmakers - led by GlaxoSmithKline and Johnson & Johnson - are stepping up efforts to ensure their medicines are available and affordable in poor countries, after being attacked...
News
27.11.2012
- Merck KGaA said it would keep its non-prescription drugs unit even as a tussle over vitamin maker Schiff Nutrition highlighted the rich sale premium it could fetch. Merck's...
